Healthcare provider profile · identity verified

Russell E Cotton, PAC

Physician Assistant · CLAYTON, AL · NPI 1417946930

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	578	173
Rosuvastatin Calcium	Rosuvastatin Calcium	367	115
Losartan Potassium	Losartan Potassium	312	89
Hydrochlorothiazide	Hydrochlorothiazide	296	85
Lisinopril	Lisinopril	275	78
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	268	75
Metformin Hcl	Metformin Hcl	267	80
Levothyroxine Sodium	Levothyroxine Sodium	266	64
Simvastatin	Simvastatin	253	68
Omeprazole	Omeprazole	245	70
Ozempic	Semaglutide	207	34
Atorvastatin Calcium	Atorvastatin Calcium	165	49
Metoprolol Tartrate	Metoprolol Tartrate	157	47
Albuterol Sulfate Hfa	Albuterol Sulfate	152	42
Potassium Chloride	Potassium Chloride	140	41
Furosemide	Furosemide	137	40
Pantoprazole Sodium	Pantoprazole Sodium	126	40
Montelukast Sodium	Montelukast Sodium	112	32
Sertraline Hcl	Sertraline Hcl	109	36
Clopidogrel	Clopidogrel Bisulfate	106	30
Hydralazine Hcl	Hydralazine Hcl	101	29
Tamsulosin Hcl	Tamsulosin Hcl	97	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	87	30
Eliquis	Apixaban	87	15
Olmesartan Medoxomil	Olmesartan Medoxomil	81	19
Clonidine Hcl	Clonidine Hcl	80	22
Carvedilol	Carvedilol	77	25
Glipizide Er	Glipizide	76	22
Naproxen	Naproxen	76	32
Tizanidine Hcl	Tizanidine Hcl	75	23
Famotidine	Famotidine	73	29
Azithromycin	Azithromycin	70	57
Fluticasone Propionate	Fluticasone Propionate	70	26
Nifedipine Er	Nifedipine	70	19
Trazodone Hcl	Trazodone Hcl	68	19
Celecoxib	Celecoxib	67	17
Xarelto	Rivaroxaban	67	12
Metoprolol Succinate	Metoprolol Succinate	61	20
Escitalopram Oxalate	Escitalopram Oxalate	60	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	57	48
Januvia	Sitagliptin Phosphate	56	15
Atenolol	Atenolol	54	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	14
Meloxicam	Meloxicam	51	16
Bisoprolol Fumarate	Bisoprolol Fumarate	50	13
Glipizide	Glipizide	50	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	14
Amoxicillin	Amoxicillin	48	42
Colchicine	Colchicine	47	14
Comfort Ez Pen Needle	Pen Needle, Diabetic	47	18
Gemfibrozil	Gemfibrozil	46	12
Linzess	Linaclotide	46	suppressed
Warfarin Sodium	Warfarin Sodium	45	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	13
Pravastatin Sodium	Pravastatin Sodium	43	11
Ezetimibe	Ezetimibe	39	11
Allopurinol	Allopurinol	38	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	18
Glimepiride	Glimepiride	38	suppressed
Entresto	Sacubitril/Valsartan	37	suppressed
Prednisone	Prednisone	37	28
Rybelsus	Semaglutide	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	21
Ondansetron Hcl	Ondansetron Hcl	35	20
Paxlovid	Nirmatrelvir/Ritonavir	34	32
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Ibuprofen	Ibuprofen	30	11
Lovastatin	Lovastatin	30	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Metformin Hcl Er	Metformin Hcl	27	11
Mounjaro	Tirzepatide	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	19
Fenofibrate	Fenofibrate	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Cilostazol	Cilostazol	21	suppressed
Ondansetron Odt	Ondansetron	21	12
Tradjenta	Linagliptin	21	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	13
Bupropion Xl	Bupropion Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	14
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Estradiol	Estradiol	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Levemir	Insulin Detemir	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Cefuroxime	Cefuroxime Axetil	15	13
Finasteride	Finasteride	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Nystatin	Nystatin	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Nitroglycerin	Nitroglycerin	14	11
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Abilify Maintena	Aripiprazole	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methimazole	Methimazole	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	12	12
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Ramipril	Ramipril	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Glyburide	Glyburide	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Restasis Multidose	Cyclosporine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error